Disinvestment and Value-Based Purchasing Strategies for Pharmaceuticals: An International Review

Disinvestment and Value-Based Purchasing Strategies for Pharmaceuticals: An International Review.

Pharmaceutical expenditure has increased rapidly across many Organisation for Economic Cooperation and Development (OECD) countries over the past three decades. This growth is an increasing concern for governments and other third-party payers seeking to provide equitable and comprehensive healthcare within sustainable budgets. In order to create headroom for increasing utilisation, and to fund ...

Strategies To Support Quality-based Purchasing: Technical Review Summary

Deficiencies in quality have been widely documented in the U.S. health care system. A recent component of purchaser response to these data has been the pursuit of quality-based purchasing (QBP). However, purchasers have been uncertain both how to measure quality and what incentives to offer to stimulate performance improvement. Furthermore, there has been dispute in the literature about the val...

Value-based Purchasing: a Review of the Literature

Development of Taiwan’s strategies for regulating nanotechnology-based pharmaceuticals harmonized with international considerations

Nanotechnology offers potential in pharmaceuticals and biomedical developments for improving drug delivery systems, medical imaging, diagnosis, cancer therapy, and regenerative medicine. Although there is no international regulation or legislation specifically for nanomedicine, it is agreed worldwide that considerably more attention should be paid to the quality, safety, and efficacy of nanotec...

Value-Based Purchasing As a Bridge Between Value and Access